Haemonetics Corporation (HAE)
HAE trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2026-03-28, https://www.sec.gov/Archives/edgar/data/313143/000031314326000050/0000313143-26-000050-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2026-03-28.
Profile
| Field | Value |
|---|---|
| Ticker | HAE on NYSE |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 1991 |
| SEC CIK | 0000313143 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | MA |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $1.3B |
| Net income | $97.3M |
| Operating income | $156.7M |
| Net margin | 7.3% |
| Operating margin | 11.7% |
| Revenue growth | -2.0% |
| Cash | $245.4M |
| Total assets | $2.4B |
| P/E (computed) | 56.8× |
| P/S (computed) | 4.1× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-05 |
| Cash and burn | $260.7M cash; operating cash flow $86.2M a quarter. | Report 2026-09-26 |
| Shares outstanding | 45,537,511 (2026-10-30); 46,809,672 a year earlier; 50,742,477 three years earlier. | Cover page 2026-10-30 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Ernst & Young LLP, Boston, Massachusetts, United States | PCAOB Form AP 2026-06-10 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $99K, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2027 2026-09-26 | $357.8M | $46.3M | $128.1M | $260.7M | $1.1B | $1.4B | 10-Q 2026-11-05 |
| Q1 2027 2026-06-27 | $339.4M | $33.0M | $52.3M | $223.4M | $1.2B | $1.4B | 10-Q 2026-08-06 |
| Q4 2026 2026-03-28 | $346.4M | -$20.1M | $70.9M | $245.4M | $1.2B | $1.3B | 10-K 2026-05-20 |
| Q3 2026 2025-12-27 | $339.0M | $44.7M | $93.6M | $363.4M | $1.2B | $1.3B | 10-Q 2026-02-05 |
| Q2 2026 2025-09-27 | $327.3M | $38.7M | $111.3M | $296.4M | $1.2B | $1.3B | 10-Q 2026-11-05 |
| Q1 2026 2025-06-28 | $321.4M | $34.0M | $17.4M | $292.9M | $1.2B | $1.3B | 10-Q 2026-08-06 |
| Q4 2025 2025-03-29 | $330.6M | $58.0M | $116.6M | $306.8M | $1.2B | $1.4B | 10-K 2026-05-20 |
| Q3 2025 2024-12-28 | $348.5M | $37.5M | $43.8M | $320.8M | $1.2B | $1.4B | 10-Q 2026-02-05 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | POS AM | 2019-07-30 |
| Latest annual report | 10-K | 2026-05-20 |
| Latest quarterly / interim | 10-Q | 2026-11-05 |
| Latest current report | 8-K | 2026-11-05 |
| Latest proxy | DEFA14A | 2026-06-09 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +2.5% |
| 1 month | +1.0% |
| 3 months | +36.0% |
| Year to date | +53.4% |
| 1 year | +66.3% |
| From 52-week high | -3.5% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| MMED | MiniMed Group Inc. | $18.65 | +3.67% | $5.2B |
| MMSI | Merit Medical Systems Inc. | $86.35 | -0.32% | $5.2B |
| TFX | Teleflex Incorporated | $157.10 | +1.51% | $6.2B |
| ICUI | ICU Medical Inc. | $181.87 | +1.45% | $4.5B |
| STVN | Stevanato Group S.p.A. | $15.53 | -1.71% | $4.2B |
| HTFL | Heartflow Inc. | $46.86 | -3.30% | $4.1B |
| NVST | Envista Holdings Corporation | $24.03 | -1.88% | $3.9B |
| PLSE | Pulse Biosciences Inc Common Stock (DE) | $46.36 | -8.09% | $3.4B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier